Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01050426
What this trial is testing

A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)

Who this might be right for
Pancreatic Cancer
Royal Marsden NHS Foundation Trust 17
Testing effectiveness (Phase 2)Looking for participantsNCT06172478
What this trial is testing

HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaHead and Neck Cancer+11 more
Daiichi Sankyo 740
Early research (Phase 1)Study completedNCT02272738
What this trial is testing

Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases 54
Not applicableActive Not RecruitingNCT06940778
What this trial is testing

LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

Who this might be right for
Cancer of RectumCancer of PancreasCancer of Stomach
Hospital do Coracao 273
Testing effectiveness (Phase 2)Study completedNCT01020006
What this trial is testing

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Who this might be right for
Pancreatic CancerDuctal AdrenocarcinomaExocrine Pancreatic Cancer
Pharmacyclics LLC. 42
Testing effectiveness (Phase 2)Study completedNCT00004884
What this trial is testing

Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 96
Testing effectiveness (Phase 2)Study completedNCT00599833
What this trial is testing

Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
The Christie NHS Foundation Trust 44
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT00026104
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
National Cancer Institute (NCI) 154
Not applicableUnknownNCT02898649
What this trial is testing

Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Yonsei University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04390399
What this trial is testing

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 328
Not applicableLooking for participantsNCT04493632
What this trial is testing

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

Who this might be right for
Pancreatic NeoplasmDigestive System NeoplasmNeoplasms by Site+5 more
OncoSil Medical Limited 500
Testing effectiveness (Phase 2)Ended earlyNCT00262951
What this trial is testing

Chemoradiation in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Ended earlyNCT00307723
What this trial is testing

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Massachusetts General Hospital 52
Testing effectiveness (Phase 2)Study completedNCT00871169
What this trial is testing

Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
New Mexico Cancer Research Alliance 61
Testing effectiveness (Phase 2)Study completedNCT00234416
What this trial is testing

IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AstraZeneca 45
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Not applicableUnknownNCT03513198
What this trial is testing

Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer
University of Medicine and Pharmacy Craiova 200
Testing effectiveness (Phase 2)UnknownNCT04089150
What this trial is testing

MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease

Who this might be right for
Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 120
Testing effectiveness (Phase 2)UnknownNCT05346146
What this trial is testing

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Who this might be right for
Unresectable Locally Advanced Pancreatic Cancer
RenJi Hospital 20
Next Page